CONFERENCE PROCEEDINGS
Advanced Search
Home > Proceedings > Volume 6427 > Article
Paper
13 March 2007 Phenylthio-substituted phthalocyanines as new photosensitizers for photodynamic therapy
Igor G Meerovich, Valentina M Derkacheva, Gennady A. Meerovich, Natalia A. Oborotova, Zoya S. Smirnova, Alevtina P. Polozkova, Irina Yu. Kubasova, Evgeny A. Lukyanets, Anatoly Yu. Baryshnikov
Author Affiliations +
Proceedings Volume 6427, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI; 64270X (2007) https://doi.org/10.1117/12.697426
Event: SPIE BiOS, 2007, San Jose, California, United States
Abstract
Current work is devoted to investigation of tetra-3-phenylthio-tetra-5-t-butylphthalocyanine [(PhS)4(t-Bu)4PcH2], aluminium hydroxyde tetra-3-phenylthiophthalocyanine [(PhS)4PcAlOH] and zinc tetra-3-phenylthiophthalocyanine [(PhS)4PcZn] as potential photosensitizers of near-infrared range. Investigations were performed on F1 mice bearing Erlich tumor. Photosensitizers were administered intravenously in liposomal form at doses of 4-10 mg/kg. Dynamic and selectivity of sensitizers' accumulation in tumor were estimated in vivo from fluorescence and absorption spectra of sensitized tissue. Photosensitizers have shown high selectivity of accumulation in tumor comparing to normal tissue of mice. Maxima of selectivity for (PhS)4(t-Bu)4PcH2, (PhS)4PcZn and (PhS)4PcAlOH achieve the values up to 2.5:1, 5:1 and 8:1 respectively. All photosensitizers completely clear from the normal tissue in 7-8 days. For PDT investigations tumors were irradiated using 732 nm laser with power density of 100-500 mW/cm2 and light dose density up to 400 J/cm2. The photodynamic efficiency was estimated using the parameter of tumor growth inhibition (TGI). All photosensitizers had shown high photodynamic efficiency of relatively large tumors. PDT using (PhS)4PcAlOH and (PhS)4(t-Bu)4PcH2 caused pronounced TGI exceeding 80%. Using (PhS)4PcZn caused moderate TGI of 60%. Investigations have shown that liposomal forms of phenylthiosubstituted phthalocyanine derivatives may be used to develop new efficient photosensitizers for PDT.
© (2007) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Citation Download Citation
Igor G Meerovich, Valentina M Derkacheva, Gennady A. Meerovich, Natalia A. Oborotova, Zoya S. Smirnova, Alevtina P. Polozkova, Irina Yu. Kubasova, Evgeny A. Lukyanets, and Anatoly Yu. Baryshnikov "Phenylthio-substituted phthalocyanines as new photosensitizers for photodynamic therapy", Proc. SPIE 6427, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI, 64270X (13 March 2007); https://doi.org/10.1117/12.697426
ACCESS THE FULL ARTICLE
ORGANIZATIONAL
Sign in with credentials provided by your organization.
INSTITUTIONAL
Select your institution to access the SPIE Digital Library.
SELECT YOUR INSTITUTION
PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
PERSONAL SIGN IN
No SPIE Account? Create one
PURCHASE THIS CONTENT
SUBSCRIBE TO DIGITAL LIBRARY
50 downloads per 1-year subscription
Members: $195
Non-members: $335 ADD TO CART
25 downloads per 1 - year subscription
Members: $145
Non-members: $250 ADD TO CART
PURCHASE SINGLE ARTICLE
Includes PDF, HTML & Video, when available
Members: $17.00
Non-members: $21.00 ADD TO CART
PROCEEDINGS
 9 PAGES
DOWNLOAD PAPER SAVE TO MY LIBRARY
GET CITATION
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors
Photodynamic therapy
Luminescence
Picosecond phenomena
Tissues
Absorption
Tissue optics
RELATED CONTENT
Subscribe to Digital Library
Receive Erratum Email Alert
Back to Top